Search

Author/Creator Park, Yeong-Min

1. A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells. (3rd October 2018)

Authors:
Kim, Young Seob; Park, Hyun Jin; Park, Jung Hwa; Hong, Eun Ji; Jang, Gun-Young; Jung, In Duk; Han, Hee Dong; Lee, Seung-Hyun; Vo, Manh-Cuong; Lee, Je-Jung; Yang, Andrew; Farmer, Emily; Wu, T.-C.; Kang, Tae Heung; Park, Yeong-Min
Journal:
Oncoimmunology
Issue:
Volume 7:Number 10(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus. (27th March 2016)

Authors:
Kim, Jong-Seok; Cha, Sang-Ho; Kim, Woo Sik; Han, Seung Jung; Cha, Seung Bin; Kim, Hong Min; Kwon, Kee Woong; Kim, So Jeong; Choi, Hong-Hee; Lee, Jienny; Cho, Sang-Nae; Koh, Won-Jung; Park, Yeong-Min; Shin, Sung Jae
Journal:
Stem cells
Issue:
Volume 34:Number 7(2016:Jul.)
Page Start:
1957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine. Issue 1 (28th February 2019)

Authors:
Park, Hyun Jin; Jang, Gun-Young; Kim, Young Seob; Park, Jung Hwa; Lee, Sung Eun; Vo, Manh-Cuong; Lee, Je-Jung; Han, Hee Dong; Jung, In Duk; Kang, Tae Heung; Park, Yeong-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation. Issue 1 (December 2017)

Authors:
Kim, Hyuk; Nam, Seung; Mun, Se; Lee, Sun-Kyeong; Kim, Hyun; Park, Young; Kim, Bokyung; Won, Kyung-Jong; Kim, Hae-Rim; Park, Yeong-Min; Kim, Hyung; Beaven, Michael; Kim, Young; Choi, Wahn
Journal:
Nature communications
Issue:
Volume 8:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches. Issue 2 (28th February 2022)

Authors:
Won, Ji Eun; Byeon, Youngseon; Wi, Tae In; Lee, Chan Mi; Lee, Ju Hyeong; Kang, Tae Heung; Lee, Jeong-Won; Lee, YoungJoo; Park, Yeong-Min; Han, Hee Dong
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer. (December 2021)

Authors:
Won, Ji Eun; Wi, Tae In; Lee, Chan Mi; Lee, Ju Hyeong; Kang, Tae Heung; Lee, Jeong-Won; Shin, Byung Cheol; Lee, YeongJoo; Park, Yeong-Min; Han, Hee Dong
Journal:
Acta biomaterialia
Issue:
Volume 136(2021)
Page Start:
508
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer. (1st January 2018)

Authors:
Kim, Ga Hee; Won, Ji Eun; Byeon, Yeongseon; Kim, Min Gi; Wi, Tae In; Lee, Jae Myeong; Park, Yun-Yong; Lee, Jeong-Won; Kang, Tae Heung; Jung, In Duk; Shin, Byung Cheol; Ahn, Hyung Jun; Lee, Young Joo; Sood, Anil K.; Han, Hee Dong; Park, Yeong-Min
Journal:
Drug delivery
Issue:
Volume 25:Number 1(2018)
Page Start:
1394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗